Pharmacological inhibition of tyrosine protein-kinase 2 reduces islet inflammation and delays type 1 diabetes onset in miceFarooq Syed, Carmella Evans‐Molina, Garrick Chang et al.|EBioMedicine|2025Cited by 14
Distinct functions and transcriptional signatures in orally induced regulatory T cell populationsMoanaro Biswas, Roland W. Herzog, Thaís B. Bertolini et al.|Frontiers in Immunology|2023Cited by 5
Pharmacological inhibition of tyrosine protein-kinase 2 reduces islet inflammation and delays type 1 diabetes onset in miceFarooq Syed, Carmella Evans‐Molina, Olivia Ballew et al.|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 3
Pharmacological Inhibition of Tyrosine Protein-Kinase 2 Reduces Islet Inflammation and Delays Type 1 Diabetes Onset in MiceFarooq Syed, Carmella Evans‐Molina, Olivia Ballew et al.|SSRN Electronic Journal|2024Cited by 3
25-OR: ADA Presidents' Select Abstract: Preclinical Evaluation of TYK2 Inhibitors in Type 1 DiabetesFAROOQ SYED, Carmella Evans‐Molina, Olivia Ballew et al.|Diabetes|2023Cited by 1